Overview

Tech Summary

Promoter Holding

Posts

LUPIN

10123456789,201234567899012345678960123456789.6012345678950123456789
+15.75 (+1.23%)
The current prices are delayed.Login/Sign Upto see live prices.
Previous Close: 1280.9
1D
5D
1M
3M
1Y
5Y
MAX
Today's low
1276.45
Today's high
1305.2
52 week low
623
52 week high
1305.2
Volume
1377103
About
TECHNICAL SUMMARY
DMA(12)
₹742.02
DMA(50)
₹708.11
DMA(100)
₹683.1
DMA(200)
₹692.55
FUNDEMANTAL SUMMARY
Market Cap
₹59023.51 Cr.
Enterprise Value
₹61974.43 Cr.
No. of Shares
45.52
P/E
60.76
RoE
3.68
Debt/Equity
0.34
Valuations
PE CHART
6080100120
PB CHART
2.53.03.54.04.5
Promoter Holdings
Public : 9.64%
FII : 13.93%
DII : 29.37%
Promoter : 47.07%
Others : 0%
Charts
DEBT/EQUITY
0.350.400.450.500.550.60
Mar, 2019Mar, 2020Mar, 2021Mar, 2022Mar, 2023
ROE VS ROCE
-10-50510
Mar, 2019Mar, 2020Mar, 2021Mar, 2022Mar, 2023
ROE
ROCE
REVENUE VS PROFITABILITY (1000CR.)
051015
Mar, 2019Mar, 2020Mar, 2021Mar, 2022Mar, 2023
Revenue
Profit
MARGINS(%)
-505101520
Mar, 2019Mar, 2020Mar, 2021Mar, 2022Mar, 2023
Net Margin
Gross Margin
Posts by FrontPage Users
NewsBot-display-image
Reputation: 181,377  •  Yesterday 4:46 PM
Lupin shares  up  0.88% as Sensex  rises
Lupin shares up 0.88% as Sensex rises
A total of 27,642 shares changed hands on the counter till 11:12AM (IST)
The Economic Times

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Shares of Lupin Ltd. gained 0.88% in Friday's session as the equity benchmark Sensex traded higher.
• The stock opened at Rs 1280.9 and has touched an intraday high and low of Rs 1296.3 and Rs 1275.95 during the session so far.
• The company reported con......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 30 4:26 PM
Lupin shares  gain  0.87% as Sensex  falls
Lupin shares gain 0.87% as Sensex falls
The stock quoted a 52-week high of Rs 1266.95 and a 52-week low of Rs 628.1.
The Economic Times

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Shares of Lupin Ltd. traded higher in Thursday's session, with the stock reaching a 52-week high of Rs 1266.95.
• For the quarter ended 30-Sep-2023, the company reported consolidated sales of Rs 5078.96 crore and net profit of Rs 489.47 crore.
• Promoter......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 29 6:36 PM
Lupin shares  gain  0.14% as Sensex  rises
Lupin shares gain 0.14% as Sensex rises
On the technical charts, the RSI of the stock stood at 65.72.
The Economic Times

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Shares of Lupin Ltd. traded slightly higher on Wednesday, despite the BSE benchmark Sensex gaining over 500 points.
• At the current price, shares of the company traded at a high P/E ratio of 42.58 and a low price-to-book value of 2.36.
• Promoters hold ......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 28 4:46 PM
Share price of Lupin  falls  as Nifty  strengthens
Share price of Lupin falls as Nifty strengthens
A total of 16,040 shares changed hands on the counter till 11:11AM (IST).
The Economic Times

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Shares of Lupin Ltd. slipped 0.45% in Tuesday's trade, with a total of 16,040 shares changing hands.
• The stock's Beta value is 0.75, indicating lower volatility compared to the broader market.
• The company reported a 5.0% increase in consolidated sale......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 28 11:16 AM
A Nifty move above 19,900 can take it to new highs: Analysts
A Nifty move above 19,900 can take it to new highs: Analysts
The breakout zone, coinciding with a bullish gap at 19,580-19,500, is viewed as robust support, and prices also defended the 19,700 level during the week, serving as immediate support.
The Economic Times

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Nifty is expected to trade within a range, with a potential move above 19,900 triggering an extended rally.
• Stocks such as Bharti Airtel, Bajaj Auto, NTPC, Jindal Stainless, RIL, Lupin, BHEL, Divi's Lab, Bharat Forge, and Oberoi Realty could attract st......read more

Vote

Comment
Share
Add a comment
Manush Vadher-display-image
Reputation: 23,633  •  Nov 27 4:03 PM

#Lupin Daily
Rising Channel formation
Resistance 1280-1300 Resistance zone
PS ~ On higher timeframe double top formation
Chartbusters - 228634027

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 24 5:53 PM
Mid-day Mood | Pharma upbeat, but benchmarks trade in a range with Nifty above 19,800
Mid-day Mood | Pharma upbeat, but benchmarks trade in a range with Nifty above 19,800
Banks are underperforming despite very good results because they are over-owned and sustained FII selling is weighing on bank stocks, said analysts.
Moneycontrol

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Banks are underperforming despite good results due to over-ownership and sustained FII selling, while midcaps and smallcaps are seeing retail exuberance.
• The Nifty Bank index has had a flat year with minimal growth, while the broader market has no valu......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 24 3:13 PM
Lupin shares trade 3% higher on tentative USFDA approvals
Lupin shares trade 3% higher on tentative USFDA approvals
On November 23, Lupin announced receiving the USFDA's tentative approval for its Abbreviated New Drug Application (ANDA) for Canagliflozin Tablets to market a generic equivalent of Invokana Tablets of Janssen Pharmaceuticals, Inc at its Pithampur facility.
Moneycontrol

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Lupin received tentative approval from the USFDA for its Abbreviated New Drug Application for Canagliflozin Tablets, a generic equivalent of Invokana Tablets.
• The company also received approval for its ANDA concerning Bromfenac Ophthalmic Solution, mak......read more

1 Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 23 10:03 PM
Lupin receives tentative approval from US FDA for diabetes medication
Lupin receives tentative approval from US FDA for diabetes medication
This product will be manufactured at Lupin’s Pithampur facility in India
Moneycontrol

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Lupin Limited has received tentative approval from the US FDA for its generic equivalent of Invokana Tablets, 100 mg and 300 mg.
• The product will be manufactured at Lupin's Pithampur facility in India.
• Canagliflozin Tablets had estimated annual sales......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 23 7:41 PM
F&O stocks: UltraTech Cement, Dr Lal PathLabs among 5 stocks with short buildup
F&O stocks: UltraTech Cement, Dr Lal PathLabs among 5 stocks with short buildup
Lets first understand how this conclusion is reached that whether the stock has seen a buildup of fresh short position or not.
The Economic Times

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• In Thursday's trading session, five stocks saw a build-up of fresh short positions, including Info Edge (India), Dr Lal PathLabs, Lupin, Voltas, and UltraTech Cement.
• Traders should also check for any bearish crossover and any extraordinary build-up of......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 23 4:38 PM
Lupin launches world’s first fixed-dose triple combination drug for chronic lung disease
Lupin launches world’s first fixed-dose triple combination drug for chronic lung disease
India has more than 37 million individuals struggling with COPD
Moneycontrol

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Lupin Limited has launched the world's first fixed-dose triple combination drug for the treatment of chronic obstructive pulmonary disease in India.
• The product will be available in a single-strength fixed dose, with a recommended once-daily dosage.
• ......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 22 5:56 PM
Lupin shares  down  0.06% as Nifty  drops
Lupin shares down 0.06% as Nifty drops
A total of 31,191 shares changed hands on the counter till 12:22PM (IST).
The Economic Times

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Shares of Lupin Ltd. traded slightly down in Wednesday's session, with a total of 31,191 shares changing hands.
• The company reported a 5.0% increase in sales for the quarter ended 30-Sep-2023, and a 277.3% increase in net profit.
• As of 30-Sep-2023, D......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 22 3:01 PM
F&O stocks to buy today: Tata Steel, Ashok Leyland among top 9 trading ideas for 22 November
F&O stocks to buy today: Tata Steel, Ashok Leyland among top 9 trading ideas for 22 November
Positive setup was seen in Oberoi Realty, MFSL, Ashok Leyland, SBI Life, Aurobindo Pharma, Astral, HDFC Life, Alkem, Lupin, JSW Steel, Titan, RIL, Exide Industries, etc. among others.
The Economic Times

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• The Indian market is expected to trade higher on Wednesday, with positive setup seen in stocks like Oberoi Realty, MFSL, Ashok Leyland, SBI Life, Aurobindo Pharma, Astral, HDFC Life, Alkem, Lupin, JSW Steel, Titan, RIL, and Exide Industries.
• Options da......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 21 4:21 PM
Share price of Lupin  jumps  as Sensex  gains  250.61 points
Share price of Lupin jumps as Sensex gains 250.61 points
A total of 4,842 shares changed hands on the counter till 10:45AM (IST)
The Economic Times

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Share price of Lupin Ltd. gained 0.91% in Tuesday's trade, with a total traded volume of 4,842 shares so far.
• The stock traded at a P/E ratio of 41.14 and a P/B ratio of 2.36, indicating investors' confidence in the company's future growth.
• Promoters......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 20 4:51 PM
Lupin shares  gain  1.22% as Sensex  falls
Lupin shares gain 1.22% as Sensex falls
The stock quoted a 52-week high of Rs 1238.15 and a 52-week low of Rs 628.1.
The Economic Times

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Shares of Lupin Ltd. traded higher in Monday's session, with the stock reaching a 52-week high of Rs 1238.15.
• For the quarter ended 30-Sep-2023, the company reported consolidated sales of Rs 5078.96 crore, up 5.0% from the previous quarter.
• Promoters......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 20 4:16 PM
Buy Lupin, target price Rs 1325:  Axis Securities
Buy Lupin, target price Rs 1325: Axis Securities
Lupin Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Services, Export Incentives and Other Operating Revenue for the year ending 31-Mar-2023.
The Economic Times

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Axis Securities has a buy call on Lupin Ltd. with a target price of Rs 1325.
• For the quarter ended 30-09-2023, the company reported a Consolidated Total Income of Rs 5078.96 Crore, up 5.00% from last quarter.
• Promoters held 47.06% stake in the compan......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 19 1:33 AM
Hold Lupin; target of Rs 1200: Prabhudas Lilladher
Hold Lupin; target of Rs 1200: Prabhudas Lilladher
Prabhudas Lilladher recommended hold rating on Lupin with a target price of Rs 1200 in its research report dated November 10, 2023.
Moneycontrol

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Prabhudas Lilladher has recommended a hold rating on Lupin with a revised target price of Rs 1200.
• The company's Q2FY24 EBITDA was 20% above estimates, aided by higher US sales.
• Lupin's margins are expected to remain healthy in the near term, but com......read more

Vote

Comment
Share
Add a comment
Vinit-display-image
Reputation: 594  •  Nov 18 12:41 AM

#LUPIN can go for buy if it breaks resistance!! 🔥
Chartbusters - chart - 222769028

2 Votes

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 17 9:28 PM
Lupin gets approval from US FDA for Ganirelix Acetate injection
Lupin gets approval from US FDA for Ganirelix Acetate injection
The product will be manufactured at Lupin’s Nagpur facility in India.
Moneycontrol

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Lupin Limited has received approval from the US FDA for its Abbreviated New Drug Application for Ganirelix Acetate Injection, which will be manufactured at the company's Nagpur facility in India.
• Ganirelix Acetate Injection is indicated for the inhibit......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 16 4:06 PM
Lupin shares  gain  1.14% as Sensex  rises
Lupin shares gain 1.14% as Sensex rises
A total of 6,241 shares changed hands on the counter till 10:30AM (IST)
The Economic Times

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Shares of Lupin Ltd. traded 1.14% higher at Rs 1184.0 at 10:30AM (IST) on Thursday, while BSE benchmark Sensex gained 126.72 points.
• The stock's 52-week high and low are Rs 1238.15 and Rs 628.1, respectively.
• At the current price, the stock trades at......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 15 9:33 PM
Hold Lupin; target of Rs 1274: Sharekhan
Hold Lupin; target of Rs 1274: Sharekhan
Sharekhan recommended Hold rating on Lupin with a target price of Rs 1274 in its research report dated November 10, 2023.
Moneycontrol

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Sharekhan has recommended a Hold rating on Lupin with a target price of Rs 1274.
• Lupin's performance for Q2FY2024 was in line with estimates, with the company reporting its highest-ever sales of USD213mn.
• Given its focus on sustaining USD200mn sales ......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 15 5:16 PM
Lupin shares  up  0.63% as Nifty  gains
Lupin shares up 0.63% as Nifty gains
A total of 5,140 shares changed hands on the counter till time (IST).
The Economic Times

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Shares of Lupin Ltd. gained 0.63% in Wednesday's trade, hitting a high of Rs 1183.6 and low of Rs 1173.35.
• The stock is currently trading above its 50-DMA and 200-DMA, indicating an upward trend.
• However, the stock is trading below the signal line of......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 13 7:57 PM
Lupin share price  down  1.46 per cent
Lupin share price down 1.46 per cent
A total of 49,417 shares changed hands on the counter till 12:58PM (IST).
The Economic Times

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Shares of Lupin Ltd. traded 1.46% higher at Rs 1162.2 on Monday, with a trading volume of 49,417 shares.
• The stock has gained 55.72% in the last year, while the Sensex has gained 12.69% during the same period.
• The company reported consolidated sales ......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 10 10:16 PM
Lupin ties up with Amman Pharma for commercialisation of biosimilar product
Lupin ties up with Amman Pharma for commercialisation of biosimilar product
Lupin has inked a licensing pact for the commercialisation and marketing of Ranibizumab, a biosimilar of Lucentis, in various countries including Saudi Arabia, UAE, Iraq and Lebanon.
The Economic Times

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Lupin has tied up with Amman Pharma to market a biosimilar product in the Middle East region.
• The company has inked a licensing pact for the commercialisation and marketing of Ranibizumab, a biosimilar of Lucentis, in various countries including Saudi ......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 10 8:33 PM
Buy Trent; target of Rs 2750 Sharekhan
Buy Trent; target of Rs 2750 Sharekhan
Sharekhan is bullish on Trent has recommended buy rating on the stock with a target price of Rs 2750 in its research report dated November 06, 2023.
Moneycontrol

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Sharekhan has recommended a buy rating on Trent with a target price of Rs. 2750.
• Trent saw strong growth in Q2FY2024, with 59% y-o-y revenue growth and 10% LFL growth.
• The stock currently trades at 39.3x/29.9x/24.1x its FY2024E/FY2025E/FY2026E EV/EBI......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 10 7:36 PM
Share price of Lupin  falls  as Sensex  drops  34.43 points
Share price of Lupin falls as Sensex drops 34.43 points
A total of 73,327 shares changed hands on the counter till 02:04PM (IST)
The Economic Times

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Share price of Lupin Ltd. dropped 1.67% to Rs 1184.55 at 02:04PM (IST) in Friday's trade.
• The stock traded at a price-to-earnings multiple of 40.54 and a price-to-book ratio of 2.36, indicating investors' willingness to pay a higher price for future gr......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 10 6:34 PM
Lupin and Amman Pharma sign licensing agreement for Ranibizumab biosimilar
Lupin and Amman Pharma sign licensing agreement for Ranibizumab biosimilar
Ranibizumab is used in the treatment of various age related eye conditions.
Moneycontrol

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Lupin Limited has entered into a strategic partnership with Amman Pharmaceuticals Industries to exclusively market and commercialize Ranibizumab biosimilar in the Middle East and select territories.
• The drug is used to treat various age-related eye con......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 10 4:01 PM
Sell Lupin, target price Rs 990:  Motilal Oswal
Sell Lupin, target price Rs 990: Motilal Oswal
Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 53688.88 Crore) operating in Pharmaceuticals sector.
The Economic Times

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Motilal Oswal has a sell call on Lupin Ltd. with a target price of Rs 990.
• For the quarter ended 30-09-2023, the company reported a Consolidated Total Income of Rs 5078.96 Crore, up 5.00% from last quarter.
• Promoters held 47.06% stake in the company ......read more

Vote

Comment
Share
Add a comment
P
Reputation: 2,264  •  Nov 9 6:08 PM

Dear Followers,

I hope you're doing well. I wanted to share a brief update regarding the short-term trend of the stock #LUPIN I have been monitoring.

Currently, the stock is experiencing a downtrend in its short-term price movement. My analysis indicates that market conditions......read more
Chartbusters - chart - 216377219

Vote

2 Comments
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 9 5:11 PM
Why Voda Idea, Tata Power are Sanjiv Bhasin 2 top bets from this Diwali to next
Why Voda Idea, Tata Power are Sanjiv Bhasin 2 top bets from this Diwali to next
“In pharma, it is better to buy a basket now than individually because select stocks have been outperformers and you want to participate in the whole basket. As a disclosure, Lupin and Aurobindo are two which we have accumulated. We still think that there is upside in both those stocks.”
The Economic Times

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Sanjiv Bhasin, Director at IIFL Securities, recommends buying a basket of pharma stocks rather than individual stocks.
• He also suggests investing in two midcap mutual funds with a pharma thematic scheme.
• Bhasin's top Diwali stock ideas are Idea and T......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 9 3:46 PM
Lupin shares  gain  0.8% as Sensex  rises
Lupin shares gain 0.8% as Sensex rises
A total of 67,682 shares changed hands on the counter till 10:15AM (IST)
The Economic Times

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Shares of Lupin Ltd. traded 0.8% higher at Rs 1221.45 at 10:15AM (IST) on Thursday, while BSE benchmark Sensex gained 44.2 points to 65019.81.
• The stock has a 52-week high of Rs 1231.6 and a 52-week low of Rs 628.1.
• At the current price, the stock tr......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 9 3:13 PM
Lupin hit 52-week high as investors cheer stellar Q2 earnings
Lupin hit 52-week high as investors cheer stellar Q2 earnings
The strong performance in the US market, aided by the launch of blockbuster respiratory drug Spiriva was the major growth driver for Lupin in Q2
Moneycontrol

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Lupin reported a stellar set of earnings for the July-September quarter, with a surge in net profit and strong revenue growth driven by the launch of blockbuster respiratory drug Spiriva in the US market.
• The company's operational performance also impr......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 8 10:56 PM
Upcoming Netflix French originals: Check out the list for your favourite series
Upcoming Netflix French originals: Check out the list for your favourite series
There is a list of upcoming films and series that will be available to the audience in 2024 like The Wages of Fear, GTMax, Nice Girls, and Fiasco.
The Economic Times

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Netflix France has several upcoming films and series, including a remake of the iconic 1953 film The Wages of Fear and a new action crime thriller called GTMax.
• The platform will also release Nice Girls, directed by Noémie Saglio, and a new series cal......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 8 9:33 PM

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Trent Ltd. has reported a 52.73% increase in net sales and a 152.34% increase in net profit for the quarter ending September 2023.
• The company's EBITDA has also increased by 64.74% compared to the same quarter last year.
• Trent's EPS has increased fro......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 8 5:16 PM
Lupin shares  gain  2.41% as Sensex  rises
Lupin shares gain 2.41% as Sensex rises
A total of 33,161 shares changed hands on the counter till 11:41AM (IST)
The Economic Times

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Shares of Lupin Ltd. traded 2.41% higher at Rs 1217.9 at 11:41AM (IST) on Wednesday, while BSE benchmark Sensex gained 26.69 points.
• The stock has a 52-week high of Rs 1224.9 and a 52-week low of Rs 628.1.
• At the prevailing price, shares of the compa......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 8 3:03 PM
Lupin share price rises on tentative USFDA approval to market 2 drugs
Lupin share price rises on tentative USFDA approval to market 2 drugs
The company has received tentative approval from the USFDA for its abbreviated new drug application (ANDA) for Canagliflozin and Metformin Hydrochloride Extended-Release Tablets.
Moneycontrol

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Lupin has received tentative approval from the USFDA for its two drugs, Canagliflozin and Metformin Hydrochloride Extended-Release Tablets.
• The products will be manufactured at Lupin's Pithampur facility in India.
• The company's board of directors wil......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 8 2:49 PM

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Trent Ltd. has reported a significant increase in net sales and net profit for the quarter ending September 2023.
• The company's EBITDA has also seen a substantial increase.
• Trent's EPS has increased from Rs. 5.23 to Rs. 8.15 in the same period.
https......read more

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 4 4:36 PM
Netflix is still growing its subscriber base – here's how a local approach is helping
Netflix is still growing its subscriber base – here's how a local approach is helping
According to its latest letter to shareholders, it added 8.8 million new subscribers in the third quarter of 2023, on top of the 5.9 million it gained in the three months before that. The total number of subscribers worldwide is now 247.2 million.
The Economic Times

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Netflix has successfully rebounded from a tough year in 2022, adding 8.8 million new subscribers in the third quarter of 2023 and gaining a total of 247.2 million worldwide.
• The company's success can be attributed to its crackdown on password sharing a......read more

Vote

Comment
Share
Add a comment
Thrifty Bull -display-image
Reputation: 2,042  •  Nov 3 2:15 AM

1 Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 2 7:23 PM
Lupin gets tentative nod from USFDA for BP drug; stock up 4%
Lupin gets tentative nod from USFDA for BP drug; stock up 4%
This approval allows Lupin to market a generic version of Uptravi for Injection, 1800 mcg/vial, which is originally produced by Actelion Pharmaceuticals US, Inc
Moneycontrol

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Lupin Limited has secured tentative approval from the US FDA for its generic version of Uptravi for Injection, 1800 mcg/vial.
• The approval will allow the company to market the product, which is used to treat pulmonary arterial hypertension, in the US.
......read more

Vote

Comment
Share
Add a comment
Himanshu Trading Zone-display-image
Reputation: 26,361  •  Nov 1 2:09 PM

SELL LUPIN BELOW 1129.40 SL 1151.45 T1 1092.40 T2 1040.20
Chartbusters - chart - 207811383

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 31 6:06 PM
Lupin shares  drop  0.57% as Sensex  rises
Lupin shares drop 0.57% as Sensex rises
The stock quoted a 52-week high of Rs 1215.2 and a 52-week low of Rs 628.1.
The Economic Times

Vote

Comment
Share
Add a comment
The Trading Teacher-display-image
Reputation: 8,256  •  Oct 29 3:33 AM

Vote

Comment
Share
Add a comment
Its Berlin here-display-image
Reputation: 11,060  •  Oct 29 2:12 AM

LUPIN LTD STOCK ANALYSIS.
Stock taking support at Trendline.
Time frame - Daily.
That's my Analysis.
I do not give any advice about buying and selling.
The information provided is for educational purposes only.
Please understand that using this information, would be tota......read more
Chartbusters - chart - 204954599

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 28 5:56 AM
Have Marwaris lost their Midas touch?
Have Marwaris lost their Midas touch?
After losing the wealth-creation plot somewhat, the wheel of fortune is once again turning the GenNext Marwari way. Higher- quality education, exposure to global management techniques and better corporate governance have rekindled a new hunger for success among GNMs - GenNext Marwaris. A fresh upsurgence is on the way.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 27 7:06 PM
Lupin shares  decline  0.81% as Sensex  climbs
Lupin shares decline 0.81% as Sensex climbs
A total of 8,793 shares changed hands on the counter till 01:34PM (IST)
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 27 7:06 AM
Is Lupin Season 4 in the cards? TV Series creator provides intriguing updates
Is Lupin Season 4 in the cards? TV Series creator provides intriguing updates
While fans eagerly await news of Lupin Season 4, series creator George Kay provides a glimpse into the potential future of the show following the captivating conclusion of Season 3.
The Economic Times

Vote

Comment
Share
Add a comment
The Money Magnet-display-image
Reputation: 12,059  •  Oct 27 4:40 AM
Post by Biswajit in Chartbusters Club on FrontPage
Post by Biswajit in Chartbusters Club on FrontPage
#LUPIN 💸💸💸💸 Time frame 1hr~Lower low formation✅~Closed at a support✅~ A good RRR trade✅~INTRADAY to SWING✅Stop loss - ab
FrontPage

5 Votes

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 27 1:56 AM
Netflix movies, series: Most watched English, non-English films, shows of streaming giant
Netflix movies, series: Most watched English, non-English films, shows of streaming giant
Netflix's most watched movies and series in the English and non-English categories have been unveiled.
The Economic Times

Vote

Comment
Share
Add a comment
The Money Magnet-display-image
Reputation: 12,059  •  Oct 24 1:25 AM

💸💸💸💸
Time frame 1hr
~Lower low formation✅
~Closed at a support✅
~ A good RRR trade✅
~INTRADAY to SWING✅
Stop loss - above support line
Target - mentioned in the chart
Chartbusters - chart - 200675979

7 Votes

1 Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 23 10:21 PM
Lupin gets USFDA nod to market generic antifungal tablets
Lupin gets USFDA nod to market generic antifungal tablets
The approval granted by the US Food and Drug Administration (USFDA) for the abbreviated new drug application of Fluconazole tablets in strengths of 50 mg, 100 mg, 150 mg and 200 mg, Lupin said in a regulatory filing.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 23 10:03 PM
Lupin receives US FDA approval for generic anti-fungal drug
Lupin receives US FDA approval for generic anti-fungal drug
The product will be manufactured at Lupin’s Pithampur facility in India. Fluconazole tablets USP had estimated annual sales of $43 million in the US according to IQVIA MAT data in July 2023
Moneycontrol

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 23 4:46 PM
Lupin stock price  down  0.97 per cent as Sensex  slides
Lupin stock price down 0.97 per cent as Sensex slides
As of 30-Sep-2023, promoters held 46.77 per cent stake in the company, while FIIs held 14.99 per cent and domestic institutional investors had 16.71 per cent.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 20 7:06 PM
Lupin shares  drop  1.86% as Sensex  falls
Lupin shares drop 1.86% as Sensex falls
On the technical charts, the RSI of the stock stood at 57.79.
The Economic Times

1 Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 19 4:46 PM
Lupin shares  gain  0.47% as Sensex  falls
Lupin shares gain 0.47% as Sensex falls
The stock quoted a 52-week high of Rs 1215.2 and a 52-week low of Rs 628.1.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 18 6:11 PM
Lupin shares  gain  0.28% as Sensex  falls
Lupin shares gain 0.28% as Sensex falls
A total of 11,469 shares changed hands on the counter till 12:38PM (IST)
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 18 6:21 AM
India Inc on long journey towards inclusion
India Inc on long journey towards inclusion
The recent Supreme Court ruling against same-sex marriages in India will not hinder the progress of inclusion in Corporate India, according to HR and diversity heads at leading companies. They believe that companies will continue to strive for inclusivity, as they have recognized the benefits it brings in terms of innovation and profitability. While a clearer verdict on marriage equality would have been helpful, companies are already taking steps to support LGBTQIA+ rights through various initiatives such as insurance coverage for partners, gender-neutral facilities, and ally programs.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 17 4:51 PM
Lupin shares  gain  1.37% as Sensex  rises
Lupin shares gain 1.37% as Sensex rises
The stock quoted a 52-week high of Rs 1214.75 and a 52-week low of Rs 628.1.
The Economic Times

Vote

Comment
Share
Add a comment
Bank Nifty-display-image
Reputation: 16,971  •  Oct 16 8:25 PM


1200 CE BTST AT 21.50

TGT 35/40

Vote

Comment
Share
Add a comment
Bank Nifty-display-image
Reputation: 16,971  •  Oct 16 4:22 PM


LUPIN 1200 CE BUY AT CMP 22.75

TGT 34/45/60

SL 15

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 16 4:01 PM
Lupin shares  rise  0.87% as Nifty  gains
Lupin shares rise 0.87% as Nifty gains
The stock quoted a 52-week high price of Rs 1201.1 and a 52-week low of Rs 628.1.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 16 7:36 AM
Lupin Season 4 Update: Creator George Kay talks about next season; Here are the details
Lupin Season 4 Update: Creator George Kay talks about next season; Here are the details
"Lupin," which debuted on Netflix in 2021, has garnered a dedicated following, thanks to its gripping storyline and outstanding performances.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 13 10:08 PM
Lupin gets tentative USFDA approval for generic prostate cancer drug
Lupin gets tentative USFDA approval for generic prostate cancer drug
The product will be manufactured at Lupin’s Pithampur facility in India.
Moneycontrol

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 13 7:31 PM
Lupin gets USFDA nod for generic medication
Lupin gets USFDA nod for generic medication
Indian drug maker Lupin has received tentative approval from the US Food and Drug Administration (FDA) to market a generic medication used to reduce excessive daytime sleepiness. Lupin plans to produce the medication at its facility in Somerset, US.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 13 7:11 PM
2 top stock recommendations from Gaurav Bissa
2 top stock recommendations from Gaurav Bissa
​On the other hand, if somebody wants to play on very ultra short-term, maybe one or two days perspective, then we are still holding above 19,500-19,550 quite strongly, even 19,600 for that matter.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 12 7:16 PM
Paytm, KPIT Tech among 7 midcap stocks which hit 52-week highs on Thursday
Paytm, KPIT Tech among 7 midcap stocks which hit 52-week highs on Thursday
Several midcap stocks achieved unprecedented milestones by reaching new 52-week highs on October 12.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 11 6:21 AM
India Inc keeping a close watch on conflict, employee safety in Israel
India Inc keeping a close watch on conflict, employee safety in Israel
​​In a statement, IT industry body Nasscom said: “We condemn the horrific act of terrorism on Israel that has led to loss of innocent lives and precipitated the conflict. The technology industry in India, we value our partnership with Israel as an innovation hub and will continue to strengthen our engagements.” As regards the current crisis, the industry has a limited presence in Israel largely focused on innovation partnerships and R&D.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 10 5:16 PM
Lupin shares  rise  0.77% as Nifty  gains
Lupin shares rise 0.77% as Nifty gains
The stock quoted a 52-week high price of Rs 1184.0 and a 52-week low of Rs 628.1.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 6 3:03 PM
Lupin shares gain on tentative USFDA nod for Tolvaptan tablets
Lupin shares gain on tentative USFDA nod for Tolvaptan tablets
This product will be manufactured at Lupin’s Nagpur facility in India.
Moneycontrol

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 5 7:11 PM
Lupin shares  decline  0.06% as Sensex  climbs
Lupin shares decline 0.06% as Sensex climbs
A total of 9,066 shares changed hands on the counter till 01:39PM (IST)
The Economic Times

Vote

Comment
Share
Add a comment
F
Reputation: 41,319  •  Oct 2 6:04 PM
Post by Finroots in Chartbusters Club on FrontPage
Post by Finroots in Chartbusters Club on FrontPage
#LUPIN Lupin In 15min Time FrameFor IntradayBuy Above____ 1115Target____ 1130___ 1150
FrontPage

1 Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 2 5:51 AM
Pharma cos can supply generic Bedaquilineto other countries
Pharma cos can supply generic Bedaquilineto other countries
Multinational pharmaceutical company Johnson & Johnson (J&J) has announced that it will not enforce secondary patents for its anti-TB drug Bedaquiline in low and middle income countries. This means that Indian pharmaceutical companies will be able to supply generic versions of the drug without the fear of litigation.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 29 8:53 PM
Lupin surges to 52-week high on receiving US FDA clearance for Nagpur unit
Lupin surges to 52-week high on receiving US FDA clearance for Nagpur unit
The US FDA classified Lupin's Nagpur unit as Voluntary Action Indicated.
Moneycontrol

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 27 3:31 PM
Shares of Lupin  rise  as Nifty  drops
Shares of Lupin rise as Nifty drops
On the technical charts, the 200-day moving average of the stock stood at Rs 828.42.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 26 6:31 PM
Lupin share price  down  0.04 per cent
Lupin share price down 0.04 per cent
A total of 5,653 shares changed hands on the counter till 12:58PM (IST).
The Economic Times

Vote

Comment
Share
Add a comment
F
Reputation: 41,319  •  Sep 26 4:10 AM


Lupin In 15min Time Frame
For Intraday
Buy Above____ 1115
Target____ 1130___ 1150
Chartbusters - chart - 174073444

2 Votes

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 25 4:26 PM
Lupin shares  gain  0.74% as Sensex  falls
Lupin shares gain 0.74% as Sensex falls
The stock quoted a 52-week high of Rs 1174.25 and a 52-week low of Rs 628.1.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 25 3:51 PM
Outlook on healthcare sector; Cipla & Sun Pharma could give 15-20% return
Outlook on healthcare sector; Cipla & Sun Pharma could give 15-20% return
ANDA approval rate has been on a steady rise post-COVID, from the low of 540 in CY21 to ~700+ annual approvals in CY23E, backed by a reduction in approval timeline and clearance of the backlog.
The Economic Times

1 Vote

Comment
Share
Add a comment
Rudra Mondal-display-image
Reputation: 3,696  •  Sep 23 5:37 AM

Lupin
5 MIN Chart target
Chartbusters - chart - 172436554

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 22 11:06 PM
Lupin inks pact to acquire 5 drug brands from Menarini for Rs 101 crore
Lupin inks pact to acquire 5 drug brands from Menarini for Rs 101 crore
Lupin said it has inked a pact to acquire five drug brands from Italian firm Menarini for Rs 101 crore. The company has signed an agreement to acquire five legacy brands catering to gastroenterology, urology and anti-infective segments, the Mumbai-based company said in a statement.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 22 10:58 PM
Lupin acquires five brands from Menarini
Lupin acquires five brands from Menarini
Lupin has been exclusively marketing these brands in the Indian market since July 2021 under a distribution and promotion agreement with A. Menarini India Private Limited.
Moneycontrol

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 22 5:46 PM
3 stocks Nithya Balasubramanian is bullish on from pharma sector
3 stocks Nithya Balasubramanian is bullish on from pharma sector
​We have seen some players recall some products. We have seen some players file bankruptcies. So these will therefore create opportunities for players with a wide portfolio.
The Economic Times

Vote

Comment
Share
Add a comment
Himanshu Trading Zone-display-image
Reputation: 26,361  •  Sep 22 2:06 PM

SELL LUPIN BELOW 1134.15 SL 1144.90.T1 1106.05 T2 1074.20
Chartbusters - chart - 170843278

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 22 12:23 AM
Saurabh Mukherjea-led Marcellus adds Trent, Rainbow Children’s Medicare to its portfolios
Saurabh Mukherjea-led Marcellus adds Trent, Rainbow Children’s Medicare to its portfolios
Consistent Compounders is the flagship portfolio that invests primarily in largecap stocks that have high cashflow. Little Champs portfolio invests primarily in smallcap stocks.
Moneycontrol

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 18 5:11 PM
Lupin stock price  down  1.29 per cent as Sensex  slides
Lupin stock price down 1.29 per cent as Sensex slides
As of 30-Jun-2023, promoters held 46.79 per cent stake in the company, while FIIs held 13.94 per cent and domestic institutional investors had 17.0 per cent.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 13 3:41 PM
Lupin shares  up  0.93% as Nifty  drops
Lupin shares up 0.93% as Nifty drops
A total of 12,150 shares changed hands on the counter till time (IST).
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 12 3:43 PM
Lupin gains 1.3% on business transfer agreement with subsidiary
Lupin gains 1.3% on business transfer agreement with subsidiary
Under the business transfer agreement, the pharma major will move the two active pharmaceutical ingredients (APIs) manufacturing sites at Dabhasa and Visakhapatnam to the subsidiary.
Moneycontrol

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 12 3:31 PM
Lupin stock price  up  2.31 per cent as Sensex  slides
Lupin stock price up 2.31 per cent as Sensex slides
As of 30-Jun-2023, promoters held 46.79 per cent stake in the company, while FIIs held 13.94 per cent and domestic institutional investors had 17.0 per cent.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 11 10:31 PM
Tata Steel, Lupin among 10 stocks with bearish RSI
Tata Steel, Lupin among 10 stocks with bearish RSI
On September 8, Friday, StockEdge reported that 27 stocks were trading in the overbought zone but had bearish or declining Relative Strength Index (RSI) trends.
The Economic Times

1 Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 11 7:26 PM
There is no risk to rally in smallcaps and broadcaps for now: Bino Pathiparampil, Elara Securities
There is no risk to rally in smallcaps and broadcaps for now: Bino Pathiparampil, Elara Securities
“We believe that flows will go more into relatively lower-valued stocks within the midcap and smallcap indices on a growth-adjusted basis. We have identified the cheapest stocks on a PEG basis and from among them, we have identified the cheapest stocks on a PEG basis and from among them, we have identified a few lists of stocks, which potentially look pretty attractive.”
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 7 12:31 PM
Stocks in news: Tata Consumer, Paytm, Safari Industries, HCL Tech, Lupin
Stocks in news: Tata Consumer, Paytm, Safari Industries, HCL Tech, Lupin
Reliance Industries' retail arm Reliance Retail has acquired a majority stake in Alia Bhatt's kid and maternity fashion brand Ed-a-Mamma.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 7 12:38 AM
Lupin ties up with Mark Cuban's Cost Plus Drugs to expand COPD drug access
Lupin ties up with Mark Cuban's Cost Plus Drugs to expand COPD drug access
This partnership aims to increase the availability of Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, to COPD patients in the United States
Moneycontrol

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Aug 31 2:31 AM
J&J, Lupin cut prices for tuberculosis drug in lower-income countries
J&J, Lupin cut prices for tuberculosis drug in lower-income countries
Johnson & Johnson and Lupin will supply their versions of the tuberculosis drug bedaquiline at a significantly cheaper price in low- and middle-income countries, according to the Stop TB Partnership. The new prices, $130 for J&J and $194 for Lupin for a six-month course of treatment, represent a 55% and 33% reduction, respectively. Bedaquiline is a key part of recommended treatment regimens for drug-resistant TB infections, and this price reduction will help broaden access to the life-saving drug.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Aug 30 3:23 PM
Lupin gains on launching heart drug in Canada
Lupin gains on launching heart drug in Canada
Lupin Pharma Canada Ltd., a wholly-owned subsidiary of Lupin, launched Propranolol LA (long-acting) capsules of 60 mg, 80 mg, 120 mg and 160 mg, in Canada
Moneycontrol

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Aug 29 3:06 PM
Stocks to buy today: Lupin Federal Bank among top 6 trading ideas for 29 August 2023
Stocks to buy today: Lupin Federal Bank among top 6 trading ideas for 29 August 2023
On the monthly options front, the maximum Call OI is placed at 19500 and then towards 19400 strikes while the maximum Put OI is placed at 19300 and then towards 19200 strikes.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Aug 29 3:01 PM
Buy Lupin, target price Rs 1165:  ICICI Direct
Buy Lupin, target price Rs 1165: ICICI Direct
Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 50629.93 Crore) operating in Pharmaceuticals sector.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Aug 28 4:56 PM
Lupin share price  up  1.43 per cent
Lupin share price up 1.43 per cent
A total of 12,644 shares changed hands on the counter till 11:21AM (IST).
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Aug 25 7:51 PM
Lupin gets USFDA nod to market generic drug for treatment of lung disease
Lupin gets USFDA nod to market generic drug for treatment of lung disease
Lupin on Friday said it has received approval from US FDA to market a generic product, used in the treatment of a lung disease, in the American market. The company has received approval from the US Food and Drug Administration (USFDA) to market Pirfenidone tablets in strengths of 267 mg and 801 mg, the Mumbai-based drug maker said in a statement.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Aug 25 7:28 PM
Lupin gets USFDA nod to market generic drug
Lupin gets USFDA nod to market generic drug
The company has received approval from the US Food and Drug Administration (USFDA) to market Pirfenidone tablets in strengths of 267 mg and 801 mg, the Mumbai-based drug maker said in a statement.
Moneycontrol

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Aug 23 6:16 PM
Lupin shares  gain  0.25% as Sensex  rises
Lupin shares gain 0.25% as Sensex rises
A total of 12,100 shares changed hands on the counter till 12:03PM (IST)
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Aug 23 5:26 PM
Buy Lupin, target price Rs 1200:  Axis Securities
Buy Lupin, target price Rs 1200: Axis Securities
Promoters held 47.07 per cent stake in the company as of 30-Jun-2023, while FIIs owned 13.93 per cent, DIIs 28.94 per cent.
The Economic Times

Vote

Comment
Share
Add a comment
Shashwat Jain-display-image
Reputation: 8,974  •  Aug 23 6:46 AM

Dark Cloud Cover in #LUPIN

Time Frame = 1 Day
Chartbusters - chart - 139026204

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Aug 22 4:06 PM
3 stocks to buy in pharma; PFC and REC good proxies for power: Rahul Shah
3 stocks to buy in pharma; PFC and REC good proxies for power: Rahul Shah
“The entire power sector is going to get rerated and there could be a lot of room for them, especially PFC and REC. If somebody wants to play a proxy to power, then these are the companies with a limited downside and there could be a good upside from here also.”
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Aug 19 3:21 AM
Lupin acquires two diabetes brands from Boehringer Ingelheim
Lupin acquires two diabetes brands from Boehringer Ingelheim
Lupin has been marketing Ondero and Ondero Met since 2015 in the Indian market as part of a co-marketing agreement with Boehringer Ingelheim and the Indian pharma company acquired the two diabetes brands for Rs 235 crore.
The Economic Times

Vote

Comment